Minor Capsid Protein of Human Genital Papillomaviruses Contains Subdominant, Cross-Neutralizing Epitopes
Open Access
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Phase IIa Safety and Immunogenicity of a Therapeutic Vaccine, TA‐GW, in Persons with Genital WartsThe Journal of Infectious Diseases, 1999
- A Surface Immunodeterminant of Human Papillomavirus Type 16 Minor Capsid Protein L2Virology, 1998
- A Peptide Encoding a B-Cell Epitope from the N-Terminus of the Capsid Protein L2 of Bovine Papillomavirus-4 Prevents DiseaseVirology, 1997
- Sequence Close to the N-terminus of L2 Protein Is Displayed on the Surface of Bovine Papillomavirus Type 1 VirionsVirology, 1997
- Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodiesJournal of General Virology, 1996
- Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic ImmunizationVirology, 1996
- Vaccination of Cattle with the N-Terminus of L2 Is Necessary and Sufficient for Preventing Infection by Bovine Papillomavirus-4Virology, 1995
- Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirusVirology, 1992
- Studies on vaccination against papillomaviruses: Prophylactic and therapeutic vaccination with recombinant structural proteinsVirology, 1991
- The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopesVirology, 1991